コンテンツへスキップ
Merck
  • Comparative in vitro anti-hepatitis C virus activities of a selected series of polymerase, protease, and helicase inhibitors.

Comparative in vitro anti-hepatitis C virus activities of a selected series of polymerase, protease, and helicase inhibitors.

Antimicrobial agents and chemotherapy (2008-07-16)
Jan Paeshuyse, Inge Vliegen, Lotte Coelmont, Pieter Leyssen, Oriana Tabarrini, Piet Herdewijn, Harald Mittendorfer, Johnny Easmon, Violetta Cecchetti, Ralf Bartenschlager, Gerhard Puerstinger, Johan Neyts
要旨

We report here a comparative study of the anti-hepatitis C virus (HCV) activities of selected (i) nucleoside polymerase, (ii) nonnucleoside polymerase, (iii) alpha,gamma-diketo acid polymerase, (iv) NS3 protease, and (v) helicase inhibitors, as well as (vi) cyclophilin binding molecules and (vii) alpha 2b interferon in four different HCV genotype 1b replicon systems.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
シクロスポリンA, 97.0-101.5% (on dried basis)
Sigma-Aldrich
シクロスポリンA, from Tolypocladium inflatum, ≥95% (HPLC), solid
Sigma-Aldrich
シクロスポリンA, BioReagent, from Tolypocladium inflatum, for molecular biology, ≥95%
Sigma-Aldrich
2-チオフェンカルボン酸, ReagentPlus®, 99%
Supelco
シクロスポリンA, VETRANAL®, analytical standard